Jun Fukihara

618 total citations
20 papers, 389 citations indexed

About

Jun Fukihara is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Oncology. According to data from OpenAlex, Jun Fukihara has authored 20 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 6 papers in Physiology and 4 papers in Oncology. Recurrent topics in Jun Fukihara's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14 papers), Sarcoidosis and Beryllium Toxicity Research (6 papers) and Medical Imaging and Pathology Studies (5 papers). Jun Fukihara is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14 papers), Sarcoidosis and Beryllium Toxicity Research (6 papers) and Medical Imaging and Pathology Studies (5 papers). Jun Fukihara collaborates with scholars based in Japan, United States and Australia. Jun Fukihara's co-authors include Yasuhiro Kondoh, Koji Sakamoto, Naozumi Hashimoto, Tomoki Kimura, Yoshinori Hasegawa, Kensuke Kataoka, Toshiaki Matsuda, Masahiro Morise, Junya Fukuoka and Atsushi Suzuki and has published in prestigious journals such as Annals of Oncology, European Respiratory Journal and Thorax.

In The Last Decade

Jun Fukihara

19 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Fukihara Japan 9 276 106 82 69 52 20 389
Sheila Segura United States 10 78 0.3× 37 0.3× 20 0.2× 12 0.2× 122 2.3× 33 318
Giuseppe Cillis Italy 8 310 1.1× 27 0.3× 128 1.6× 47 0.7× 3 0.1× 10 378
Hanjin Yang China 8 68 0.2× 49 0.5× 12 0.1× 40 0.6× 7 0.1× 22 234
A. Forgione Italy 7 76 0.3× 53 0.5× 65 0.8× 10 0.1× 5 0.1× 16 282
Khaled Dawas United Kingdom 9 87 0.3× 44 0.4× 54 0.7× 10 0.1× 8 0.2× 22 254
Akiou Okumura Japan 10 54 0.2× 37 0.3× 17 0.2× 22 0.3× 57 1.1× 38 312
Aeran Seol South Korea 9 33 0.1× 47 0.4× 18 0.2× 26 0.4× 168 3.2× 31 351
Akiko Abe Japan 12 52 0.2× 51 0.5× 12 0.1× 18 0.3× 157 3.0× 35 307
Melissa Robbie Australia 6 69 0.3× 29 0.3× 9 0.1× 29 0.4× 111 2.1× 10 366
Hamdullah Sözen Türkiye 11 34 0.1× 29 0.3× 10 0.1× 48 0.7× 158 3.0× 44 297

Countries citing papers authored by Jun Fukihara

Since Specialization
Citations

This map shows the geographic impact of Jun Fukihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Fukihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Fukihara more than expected).

Fields of papers citing papers by Jun Fukihara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Fukihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Fukihara. The network helps show where Jun Fukihara may publish in the future.

Co-authorship network of co-authors of Jun Fukihara

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Fukihara. A scholar is included among the top collaborators of Jun Fukihara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Fukihara. Jun Fukihara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matsuda, Toshiaki, Yasuhiro Kondoh, Reoto Takei, et al.. (2024). Responsiveness and minimal clinically important difference of the COPD Assessment Test in fibrotic interstitial lung disease. Respiratory Investigation. 62(6). 1088–1093. 2 indexed citations
2.
Furukawa, Taiki, Jun Fukihara, Yasuhiko Yamano, et al.. (2024). Mild elevation of pulmonary vascular resistance predicts mortality regardless of mean pulmonary artery pressure in mild interstitial lung disease. Thorax. 79(5). 422–429. 5 indexed citations
3.
Fukihara, Jun, Koji Sakamoto, Taiki Furukawa, et al.. (2024). Mitochondrial DNA in bronchoalveolar lavage fluid is associated with the prognosis of idiopathic pulmonary fibrosis: a single cohort study. Respiratory Research. 25(1). 202–202. 4 indexed citations
4.
Takei, Reoto, Toshiaki Matsuda, Jun Fukihara, et al.. (2023). Changes in patient-reported outcomes in patients with non-idiopathic pulmonary fibrosis fibrotic interstitial lung disease and progressive pulmonary fibrosis. Frontiers in Medicine. 10. 1067149–1067149. 7 indexed citations
5.
Fukihara, Jun & Yasuhiro Kondoh. (2023). COVID-19 and interstitial lung diseases: A multifaceted look at the relationship between the two diseases. Respiratory Investigation. 61(5). 601–617. 10 indexed citations
6.
Takei, Reoto, Yasuhiko Yamano, Kensuke Kataoka, et al.. (2023). Disease progression and changes in KL-6 in patients with limited cutaneous systemic sclerosis-associated interstitial lung disease. Respiratory Investigation. 62(1). 44–48. 1 indexed citations
7.
Suzuki, Atsushi, Kensuke Fukumitsu, Jun Fukihara, et al.. (2023). Effectiveness of remdesivir-based therapy for moderate COVID-19: comparison of Omicron and other variant phases. Journal of Chemotherapy. 36(2). 127–132.
8.
9.
Suzuki, Atsushi, Koji Sakamoto, Yoshio Nakahara, et al.. (2022). BMP3b is a Novel Antifibrotic Molecule Regulated by Meflin in Lung Fibroblasts. American Journal of Respiratory Cell and Molecular Biology. 67(4). 446–458. 7 indexed citations
10.
Sakamoto, Koji, Jun Fukihara, Atsushi Suzuki, et al.. (2022). COVID-19-Triggered Acute Exacerbation of IPF, an Underdiagnosed Clinical Entity With Two-Peaked Respiratory Failure: A Case Report and Literature Review. Frontiers in Medicine. 9. 815924–815924. 7 indexed citations
11.
12.
Sakamoto, Koji, Jun Fukihara, Masahiro Morise, & Naozumi Hashimoto. (2020). Clinical burden of immune checkpoint inhibitor-induced pneumonitis. Respiratory Investigation. 58(5). 305–319. 13 indexed citations
13.
Fukihara, Jun, Yasuhiro Kondoh, Kevin K. Brown, et al.. (2020). Probable usual interstitial pneumonia pattern on chest CT: is it sufficient for a diagnosis of idiopathic pulmonary fibrosis?. European Respiratory Journal. 55(4). 1802465–1802465. 24 indexed citations
14.
Fukihara, Jun, Koji Sakamoto, Junji Koyama, et al.. (2019). Prognostic Impact and Risk Factors of Immune-Related Pneumonitis in Patients With Non–Small-Cell Lung Cancer Who Received Programmed Death 1 Inhibitors. Clinical Lung Cancer. 20(6). 442–450.e4. 76 indexed citations
15.
Suzuki, Atsushi, Yasuhiro Kondoh, Kevin K. Brown, et al.. (2019). Acute exacerbations of fibrotic interstitial lung diseases. Respirology. 25(5). 525–534. 103 indexed citations
16.
Koyama, Junji, Tomoki Kimura, Yasuhiko Yamano, et al.. (2019). Immune checkpoint inhibitor for advanced or recurrent non-small cell lung cancer patients with poor performance status. Annals of Oncology. 30. vi141–vi141. 1 indexed citations
17.
Fukihara, Jun, Hiroyuki Taniguchi, Masahiko Ando, et al.. (2017). Hemosiderin-laden macrophages are an independent factor correlated with pulmonary vascular resistance in idiopathic pulmonary fibrosis: a case control study. BMC Pulmonary Medicine. 17(1). 30–30. 16 indexed citations
18.
Fukihara, Jun & Yasuhiro Kondoh. (2016). Nintedanib (OFEV) in the treatment of idiopathic pulmonary fibrosis. Expert Review of Respiratory Medicine. 10(12). 1247–1254. 19 indexed citations
19.
Fukihara, Jun, Naohiro Watanabe, Hiroyuki Taniguchi, et al.. (2014). Clinical Predictors of Response to EGFR Tyrosine Kinase Inhibitors in Patients with EGFR-Mutant Non-Small Cell Lung Cancer. Oncology. 86(2). 86–93. 19 indexed citations
20.
Jijiwa, Mayumi, Kumi Kawai, Jun Fukihara, et al.. (2008). GDNF‐mediated signaling via RET tyrosine 1062 is essential for maintenance of spermatogonial stem cells. Genes to Cells. 13(4). 365–374. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sheila Segura Breakdown of academic impact, for papers by Giuseppe Cillis Breakdown of academic impact, for papers by Hanjin Yang Breakdown of academic impact, for papers by A. Forgione Breakdown of academic impact, for papers by Khaled Dawas Breakdown of academic impact, for papers by Akiou Okumura Breakdown of academic impact, for papers by Aeran Seol Breakdown of academic impact, for papers by Akiko Abe Breakdown of academic impact, for papers by Melissa Robbie Breakdown of academic impact, for papers by Hamdullah Sözen
Rankless by CCL
2026